LORI HOWELL: Open Payments
NPI 1366999799 · LAUREL, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,159 in 147 payments from 15 companies in 2025. Trend: 2023 $1,777 · 2024 $1,862 · 2025 $2,159
Food & beverage: $2,149Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $459 |
| Novartis Pharmaceuticals Corporation | 22 | $333 |
| UCB, Inc. | 28 | $275 |
| GENZYME CORPORATION | 10 | $174 |
| E.R. Squibb & Sons, L.L.C. | 4 | $159 |
| LEO Pharma Inc. | 8 | $156 |
| Amgen Inc. | 9 | $151 |
| Galderma Laboratories, L.P. | 16 | $144 |
| Lilly USA, LLC | 6 | $130 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $41 |
Products named: SKYRIZI, COSENTYX, Bimzelx, DUPIXENT, Sotyktu, OTEZLA, NEMLUVIO, RINVOQ.
Industry payments across MS — which companies pay providers there.
